Background: The aim of this study was to evaluate the correlation between gender, and drug allergy agent and its incidence frequency.
Material and Methods: The population of this retrospective study included individuals who applied to the polyclinics for any reason between 2015 and 2021 and who reported a drug allergy. The total numbers of applications, number of examinations, gender, and the presence of drug allergy and the drug allergy agent were recorded in the data form using the archive review method. Data were analyzed with the IBM SPSS V23.
Results: The total number of applications to the polyclinic was 151.036 and the number of singular patient applications was 31.915. Among 31.915 patients, 312 patients reported a drug allergy. Of these patients, 79 (25.3%) were male and 233 (74.7%) were female. The most common allergen reported was penicillin, and 58.2% of men and 45.5% of women had this allergy. No statistically significant difference was found between the distributions of allergen agents based on gender (p>0.096). There was a significant difference only between Gadobutrol and gender, and a correlation was found with male gender (p=0.021). No correlation was found when drug agents were dived into groups.
Conclusion: Since it has become easy to access healthcare services as well as drugs, the incidence frequency of drug allergies has also increased. Although it is predicted that gender might be effective in the occurrence of drug allergies due to hormonal and genetic differences, no correlation was found in this study. Thus, it should be noted that the risk of drug allergy incidence might exist for both genders.
-
-
We thank Yücel Özalp (ozalpyucel@gmail.com, from Brussels, Belgium) for the illustration drawing of Figure 1.
-
Birincil Dil | İngilizce |
---|---|
Konular | İç Hastalıkları |
Bölüm | Araştırma Makaleleri |
Yazarlar | |
Proje Numarası | - |
Yayımlanma Tarihi | 30 Ekim 2021 |
Yayımlandığı Sayı | Yıl 2021 Cilt: 6 Sayı: 3 |
Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.